Literature DB >> 2930766

The rabbit as an animal model of hepatic lipase deficiency.

M A Clay1, G J Hopkins, C P Ehnholm, P J Barter.   

Abstract

A natural deficiency of hepatic lipase in rabbits has been exploited to gain insights into the physiological role of this enzyme in the metabolism of plasma lipoproteins. A comparison of human and rabbit lipoproteins revealed obvious species differences in both low-density lipoproteins (LDL) and high-density lipoproteins (HDL), with the rabbit lipoproteins being relatively enlarged, enriched in triacylglycerol and depleted of cholesteryl ester. To test whether these differences related to the low level of hepatic lipase in rabbits, whole plasma or the total lipoprotein fraction from rabbits was either kept at 4 degrees C or incubated at 37 degrees C for 7 h in (i) the absence of lipase, (ii) the presence of hepatic lipase and (iii) the presence of lipoprotein lipase. Following incubation, the lipoproteins were recovered and subjected to gel permeation chromatography to determine the distribution of lipoprotein components across the entire lipoprotein spectrum. An aliquot of the lipoproteins was subjected also to gradient gel electrophoresis to determine the particle size distribution of the LDL and HDL. Both hepatic lipase and lipoprotein lipase hydrolysed lipoprotein triacylglycerol and to a much lesser extent, also phospholipid. There were, however, obvious differences between the enzymes in terms of substrate specificity. In incubations containing hepatic lipase, there was a preferential hydrolysis of HDL triacylglycerol and a lesser hydrolysis of VLDL triacylglycerol. By contrast, lipoprotein lipase acted primarily on VLDL triacylglycerol. When more enzyme was added, both lipases also acted on LDL triacylglycerol, but in no experiment did lipoprotein lipase hydrolyse the triacylglycerol in HDL. Coincident with the hepatic lipase-induced hydrolysis of LDL and HDL triacylglycerol, there were marked reductions in the particle size of both lipoprotein fractions, which were now comparable to those of human LDL and HDL3, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930766     DOI: 10.1016/0005-2760(89)90284-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Biochemical characterization of cholesteryl ester transfer protein inhibitors.

Authors:  Mollie Ranalletta; Kathleen K Bierilo; Ying Chen; Denise Milot; Qing Chen; Elaine Tung; Caroline Houde; Nadine H Elowe; Margarita Garcia-Calvo; Gene Porter; Suzanne Eveland; Betsy Frantz-Wattley; Mike Kavana; George Addona; Peter Sinclair; Carl Sparrow; Edward A O'Neill; Ken S Koblan; Ayesha Sitlani; Brian Hubbard; Timothy S Fisher
Journal:  J Lipid Res       Date:  2010-05-10       Impact factor: 5.922

Review 2.  Atherosclerosis: Making a U Turn.

Authors:  Ira J Goldberg; Gaurav Sharma; Edward A Fisher
Journal:  Annu Rev Med       Date:  2020-01-27       Impact factor: 13.739

3.  Macrophages enhance binding of beta-VLDL and cholesterol ester accumulation in cultured aortic smooth muscle cells.

Authors:  R E Rennick; J H Campbell; G R Campbell
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

4.  Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.

Authors:  Wu Yin; Ester Carballo-Jane; David G McLaren; Vivienne H Mendoza; Karen Gagen; Neil S Geoghagen; Lesley Ann McNamara; Judith N Gorski; George J Eiermann; Aleksandr Petrov; Michael Wolff; Xinchun Tong; Larissa C Wilsie; Taro E Akiyama; Jing Chen; Anil Thankappan; Jiyan Xue; Xiaoli Ping; Genevieve Andrews; L Alexandra Wickham; Cesaire L Gai; Tu Trinh; Alison A Kulick; Marcie J Donnelly; Gregory O Voronin; Ray Rosa; Anne-Marie Cumiskey; Kavitha Bekkari; Lyndon J Mitnaul; Oscar Puig; Fabian Chen; Richard Raubertas; Peggy H Wong; Barbara C Hansen; Ken S Koblan; Thomas P Roddy; Brian K Hubbard; Alison M Strack
Journal:  J Lipid Res       Date:  2011-10-23       Impact factor: 5.922

5.  Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits.

Authors:  F I Romero; M J Martínez-Calatrava; O Sánchez-Pernaute; O Gualillo; R Largo; G Herrero-Beaumont
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

Authors:  M E Brousseau; S Santamarina-Fojo; L A Zech; A M Bérard; B L Vaisman; S M Meyn; D Powell; H B Brewer; J M Hoeg
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

7.  Hepatic lipase function and the accumulation of beta-very-low-density lipoproteins in the plasma of cholesterol-fed rabbits.

Authors:  S Chang; J Borensztajn
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

8.  Tibolone inhibits aortic atherosclerotic lesionformation in oophorectomized cholesterol-fed rabbits.

Authors:  Camil Castelo-Branco; Alex Sanjuán; Carles Ascaso; Marta Colodrón; Juan Enrique Blümel; Elena Casals; Jaume Ordi; Juan Antonio Vanrell
Journal:  Exp Clin Cardiol       Date:  2003

9.  Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

Authors:  S Eisenberg; E Sehayek; T Olivecrona; I Vlodavsky
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

10.  Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins.

Authors:  J Fan; J Wang; A Bensadoun; S J Lauer; Q Dang; R W Mahley; J M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.